Table 4 Serum MU5AC positivity in each clinicopathologic parameters
From: Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma
| MUC5AC Ab negative | MUC5AC Ab positive | ||||
|---|---|---|---|---|---|
| N | (%) | N | (%) | ||
| Age | |||||
| ≤60 | (5) | 29.4 | (12) | 70.6 | |
| >60 | (7) | 53.8 | (6) | 46.2 | |
| (p = 0.176) | |||||
| Sex | |||||
| Female | (8) | 66.7 | (4) | 33.3 | |
| Male | (4) | 22.2 | (14) | 77.8 | |
| (p = 0.015) | |||||
| Tumor Location | |||||
| Colon | (8) | 33.3 | (16) | 66.7 | |
| Rectum | (4) | 66.7 | (2) | 33.3 | |
| (p = 0.116) | |||||
| Duke's Stage | |||||
| B | (4) | 50.0 | (4) | 50.0 | |
| C | (6) | 54.5 | (5) | 45.5 | |
| D | (27) | 31.3 | (8) | 72.7 | |
| (p = 0.25) | |||||
| Histologic type | |||||
| Adeno Ca | (12) | 44.4 | (15) | 55.6 | |
| Mucinous Ca | - | - | (1) | 100 | |
| Adenosquamous Ca | - | - | (1) | 100 | |
| Adenocarcinoid Ca | - | - | (1) | 100 | |
| (p = 0.528) | |||||
| Differentiation | |||||
| Well | (3) | 50.0 | (3) | 50.0 | |
| Moderate | (9) | 47.4 | (10) | 52.6 | |
| Poor | - | - | (4) | 100 | |
| Mucinous | - | - | (1) | 100 | |
| (p = 0.260) | |||||
| Metastatic Lymph Node | |||||
| Absent | (3) | 37.5 | (5) | 62.5 | |
| Present | (9) | 40.9 | (3) | 59.1 | |
| (p = 0.866) | |||||
| Preoperative Metastasis | |||||
| Absent | (9) | 47.4 | (10) | 52.6 | |
| Present | (27) | 31.3 | (8) | 72.7 | |
| (p = 0.219) | |||||
